Literature DB >> 26661236

Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress.

Ravi K Sajja1, Shafiqur Rahman2, Luca Cucullo3.   

Abstract

Psychostimulants and nicotine are the most widely abused drugs with a detrimental impact on public health globally. While the long-term neurobehavioral deficits and synaptic perturbations are well documented with chronic use of methamphetamine, cocaine, and nicotine, emerging human and experimental studies also suggest an increasing incidence of neurovascular complications associated with drug abuse. Short- or long-term administration of psychostimulants or nicotine is known to disrupt blood-brain barrier (BBB) integrity/function, thus leading to an increased risk of brain edema and neuroinflammation. Various pathophysiological mechanisms have been proposed to underlie drug abuse-induced BBB dysfunction suggesting a central and unifying role for oxidative stress in BBB endothelium and perivascular cells. This review discusses drug-specific effects of methamphetamine, cocaine, and tobacco smoking on brain microvascular crisis and provides critical assessment of oxidative stress-dependent molecular pathways focal to the global compromise of BBB. Additionally, given the increased risk of human immunodeficiency virus (HIV) encephalitis in drug abusers, we have summarized the synergistic pathological impact of psychostimulants and HIV infection on BBB integrity with an emphasis on unifying role of endothelial oxidative stress. This mechanistic framework would guide further investigations on specific molecular pathways to accelerate therapeutic approaches for the prevention of neurovascular deficits by drugs of abuse.
© The Author(s) 2015.

Entities:  

Keywords:  Drug abuse; alternative; blood-brain barrier; cocaine; methamphetamine; nicotine; oxidative stress; tight junctions

Mesh:

Substances:

Year:  2015        PMID: 26661236      PMCID: PMC4794105          DOI: 10.1177/0271678X15616978

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  150 in total

Review 1.  Psychostimulant abuse and neuroinflammation: emerging evidence of their interconnection.

Authors:  Kenneth H Clark; Clayton A Wiley; Charles W Bradberry
Journal:  Neurotox Res       Date:  2012-06-20       Impact factor: 3.911

2.  Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.

Authors:  Carola Förster; Malgorzata Burek; Ignacio A Romero; Babette Weksler; Pierre-Olivier Couraud; Detlev Drenckhahn
Journal:  J Physiol       Date:  2008-02-07       Impact factor: 5.182

Review 3.  Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.

Authors:  Danica B Stanimirovic; Mahmud Bani-Yaghoub; Martin Perkins; Arsalan S Haqqani
Journal:  Expert Opin Drug Discov       Date:  2014-11-12       Impact factor: 6.098

Review 4.  Tobacco smoke and cardiovascular risk: a call for continued efforts to reduce exposure.

Authors:  Paul Frey; David D Waters
Journal:  Curr Opin Cardiol       Date:  2011-09       Impact factor: 2.161

Review 5.  HIV-associated neurocognitive disorders (HAND).

Authors:  Daniel Elbirt; Keren Mahlab-Guri; Shira Bezalel-Rosenberg; Harpreet Gill; Malka Attali; Ilan Asher
Journal:  Isr Med Assoc J       Date:  2015-01       Impact factor: 0.892

6.  Methamphetamine causes sustained depression in cerebral blood flow.

Authors:  Oksana Polesskaya; Jharon Silva; Christine Sanfilippo; Taylor Desrosiers; Anita Sun; Jie Shen; Changyong Feng; Aleksey Polesskiy; Rashid Deane; Berislav Zlokovic; Karl Kasischke; Stephen Dewhurst
Journal:  Brain Res       Date:  2010-12-13       Impact factor: 3.252

Review 7.  Alteration of blood-brain barrier function by methamphetamine and cocaine.

Authors:  J B Dietrich
Journal:  Cell Tissue Res       Date:  2009-04-07       Impact factor: 5.249

8.  Cocaine-mediated alteration in tight junction protein expression and modulation of CCL2/CCR2 axis across the blood-brain barrier: implications for HIV-dementia.

Authors:  Navneet K Dhillon; Fuwang Peng; Sirosh Bokhari; Shannon Callen; Sun-Hye Shin; Xuhui Zhu; Kee-Jun Kim; Shilpa J Buch
Journal:  J Neuroimmune Pharmacol       Date:  2007-11-29       Impact factor: 4.147

9.  Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse.

Authors:  Supriya D Mahajan; Ravikumar Aalinkeel; Donald E Sykes; Jessica L Reynolds; B Bindukumar; Adaffaras Adal; Mingshen Qi; Jennifer Toh; Gaixia Xu; Paras N Prasad; Stanley A Schwartz
Journal:  Brain Res       Date:  2008-02-13       Impact factor: 3.252

10.  Methamphetamine-induced occludin endocytosis is mediated by the Arp2/3 complex-regulated actin rearrangement.

Authors:  Minseon Park; Hyun-Jung Kim; Brian Lim; Adam Wylegala; Michal Toborek
Journal:  J Biol Chem       Date:  2013-09-30       Impact factor: 5.157

View more
  50 in total

Review 1.  E-cigarette use as a potential cardiovascular disease risk behavior.

Authors:  Krysten W Bold; Suchitra Krishnan-Sarin; Catherine M Stoney
Journal:  Am Psychol       Date:  2018-11

2.  Effect of Cigarette Smoking on a Marker for Neuroinflammation: A [11C]DAA1106 Positron Emission Tomography Study.

Authors:  Arthur L Brody; Robert Hubert; Ryutaro Enoki; Lizette Y Garcia; Michael S Mamoun; Kyoji Okita; Edythe D London; Erika L Nurmi; Lauren C Seaman; Mark A Mandelkern
Journal:  Neuropsychopharmacology       Date:  2017-03-06       Impact factor: 7.853

3.  Conditional Effects of Lifetime Alcohol Consumption on Methamphetamine-Associated Neurocognitive Performance.

Authors:  Rowan Saloner; Emily W Paolillo; Anya Umlauf; David J Moore; Robert K Heaton; Igor Grant; Mariana Cherner
Journal:  J Int Neuropsychol Soc       Date:  2019-06-10       Impact factor: 2.892

4.  Effect of methamphetamine on the fasting blood glucose in methamphetamine abusers.

Authors:  Yanhong Zhang; Guofang Shu; Ying Bai; Jie Chao; Xufeng Chen; Honghong Yao
Journal:  Metab Brain Dis       Date:  2018-06-26       Impact factor: 3.584

5.  Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists.

Authors:  Mark E Orcholski; Ke Yuan; Charlotte Rajasingh; Halley Tsai; Elya A Shamskhou; Navneet K Dhillon; Norbert F Voelkel; Roham T Zamanian; Vinicio A de Jesus Perez
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-08       Impact factor: 5.464

Review 6.  Thrombolytic Therapy in Cocaine Users with Ischemic Stroke: A Review of Current Practice.

Authors:  Antonio Siniscalchi; Giovambattista De Sarro; Roberta Pacifici; Ermanno Pisani; Sandro Sanguigni; Luca Gallelli
Journal:  Psychopharmacol Bull       Date:  2019-02-15

7.  Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes.

Authors:  Irma E Cisneros; Mert Erdenizmenli; Kathryn A Cunningham; Slobodan Paessler; Kelly T Dineley
Journal:  Neuropharmacology       Date:  2018-03-23       Impact factor: 5.250

8.  Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron.

Authors:  José Vicente Lafuente; Aruna Sharma; Dafin F Muresanu; Asya Ozkizilcik; Z Ryan Tian; Ranjana Patnaik; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

9.  Cold Environment Exacerbates Brain Pathology and Oxidative Stress Following Traumatic Brain Injuries: Potential Therapeutic Effects of Nanowired Antioxidant Compound H-290/51.

Authors:  Aruna Sharma; Dafin F Muresanu; José Vicente Lafuente; Per-Ove Sjöquist; Ranjana Patnaik; Z Ryan Tian; Asya Ozkizilcik; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

10.  Hyperglycemia exacerbates antiretroviral drug combination induced blood-brain barrier endothelial toxicity.

Authors:  Shikha Prasad; Ravi K Sajja; Mohammad A Kaisar; Luca Cucullo
Journal:  Neurotoxicology       Date:  2016-06-23       Impact factor: 4.294

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.